Tolera Therapeutics' Debt - IV Round

Tolera Therapeutics raised a round of funding on September 28, 2013.

Tolera Therapeutics is developing targeted therapies for immune suppression and immune tolerance, designed for use in organ transplant surgeries and other medical settings requiring safer, more target…

Articles about Tolera Therapeutics' Debt - IV Round: